Arkolith/Insider Trading/LXRX/Form 4

Gopinathan Suma

SVP, DiscoveryLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2026Grant(A)358K—$0358K
Feb 12, 2026Grant(A)238K—$0238K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML